Cargando…
Targeting of Tetraspanin CD81 with Monoclonal Antibodies and Small Molecules to Combat Cancers and Viral Diseases
SIMPLE SUMMARY: Novel therapeutic targets are needed to improve treatments of aggressive cancers and viral diseases. Tetraspanins represent an emerging class of anticancer targets, notably the transmembrane protein CD81 which has been structurally well characterized. CD81 plays key roles in tumor gr...
Autores principales: | Bailly, Christian, Thuru, Xavier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093296/ https://www.ncbi.nlm.nih.gov/pubmed/37046846 http://dx.doi.org/10.3390/cancers15072186 |
Ejemplares similares
-
A new panel of epitope mapped monoclonal antibodies recognising the prototypical tetraspanin CD81
por: Grove, Joe, et al.
Publicado: (2017) -
Tetraspanin CD81 regulates HSV-1 infection
por: Benayas, Beatriz, et al.
Publicado: (2020) -
Tetraspanins CD9 and CD81 function to prevent the fusion of mononuclear phagocytes
por: Takeda, Yoshito, et al.
Publicado: (2003) -
Tetraspanin CD81 is an adverse prognostic marker in acute myeloid leukemia
por: Boyer, Thomas, et al.
Publicado: (2016) -
The Tetraspanin CD81 Is a Host Factor for Chikungunya Virus Replication
por: Lasswitz, Lisa, et al.
Publicado: (2022)